A detailed history of Gds Wealth Management transactions in Biote Corp. stock. As of the latest transaction made, Gds Wealth Management holds 42,789 shares of BTMD stock, worth $261,012. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,789
Previous 57,789 25.96%
Holding current value
$261,012
Previous $431,000 44.78%
% of portfolio
0.02%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$5.33 - $8.36 $79,950 - $125,399
-15,000 Reduced 25.96%
42,789 $238,000
Q2 2024

Aug 09, 2024

BUY
$5.44 - $7.47 $314,372 - $431,683
57,789 New
57,789 $431,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $46.2M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Gds Wealth Management Portfolio

Follow Gds Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gds Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Gds Wealth Management with notifications on news.